Richard D Francis sold $1.3M of TEVA
President and CEO at TEVA PHARMACEUTICAL INDUSTRIES LTD. 75,506 shares at an average of $16.95, traded Feb 18, 2025, filed Feb 19, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.3M at market
- +10Share of holdings soldSold 26% of holdings
- +15Cluster5 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-25-023126, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 15, 2025 | MOption exercise Ordinary Shares10b5-1 | +161,655 | - | - | 284,950 | Feb 19, 2025 |
| Feb 18, 2025 | SOpen-market sale Ordinary Shares10b5-1 | -75,506 | $16.95 | $1.3M | 209,444 | Feb 19, 2025 |
| Feb 15, 2025 | MOption exercise Restricted Share Unitsderivative10b5-1 | -161,655 | $0.00 | $0 | 161,656 | Feb 19, 2025 |
Related signals
Other insiders at TEVA PHARMACEUTICAL INDUSTRIES LTD and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 68Notable | TEVA PHARMACEUTICAL INDUSTRIES LTD | Roberto Mignone director | $14M 367,600 shares | -100% | |
| 32Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Brian Savage Interim Chief Legal Officer | $285k 7,342 shares | -46% | |
| 45Moderate | TEVAsell TEVA PHARMACEUTICAL INDUSTRIES LTD | Richard Daniell Exec. VP, European Commercial | $3.3M 115,468 shares | -70% | |
| 11Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Christine Fox EVP, Head of U.S. Commercial | $700k 28,229 shares | -31% | |
| 57Moderate | TEVAsell TEVA PHARMACEUTICAL INDUSTRIES LTD | Christine Fox EVP, Head of U.S. Commercial | $753k 30,000 shares | -51% | |
| 22Weak | TEVAbuy TEVA PHARMACEUTICAL INDUSTRIES LTD | David R. McAvoy EVP, Chief Legal Officer | $21k 1,113 shares | +9% | |
| 30Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Eric A Hughes See "Remarks" | $799k 52,742 shares | -100% | |
| 27Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Placid Jover See "Remarks" | $92k 6,053 shares | -47% | |
| 39Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Eliyahu Sharon Kalif EVP, Chief Financial Officer | $952k 55,775 shares | -12% | |
| 28Weak | TEVA PHARMACEUTICAL INDUSTRIES LTD | Matthew Shields EVP, Global Operations | $106k 6,206 shares | -38% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.